SCOPUS 정보 검색 플랫폼

Current Biology

Volumn 22, Issue 18, 2012, Pages

DNA damage: Placing BRCA1 in the proper context

(2) Aressy, Bernadette a Greenberg, Roger A a

a UNIVERSITY OF PENNSYLVANIA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866654161 PISSN: 09609822 EISSN: None Source Type: Journal
DOI: 10.1016/j.cub.2012.07.046 Document Type: Short Survey

Times cited : (7)

References (17)

1
- 17244375049
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
- DOI 10.1038/nature03443
- H.E. Bryant, N. Schultz, H.D. Thomas, K.M. Parker, D. Flower, E. Lopez, S. Kyle, M. Meuth, N.J. Curtin, and T. Helleday Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase Nature 434 2005 913 917 (Pubitemid 40559005)
- (2005) Nature , vol.434 , Issue.7035 , pp. 913-917
- Bryant, H.E.¹ Schultz, N.² Thomas, H.D.³ Parker, K.M.⁴ Flower, D.⁵ Lopez, E.⁶ Kyle, S.⁷ Meuth, M.⁸ Curtin, N.J.⁹ Helleday, T.¹⁰

2
- 17244373777
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
- DOI 10.1038/nature03445
- H. Farmer, N. McCabe, C.J. Lord, A.N. Tutt, D.A. Johnson, T.B. Richardson, M. Santarosa, K.J. Dillon, I. Hickson, and C. Knights Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy Nature 434 2005 917 921 (Pubitemid 40559006)
- (2005) Nature , vol.434 , Issue.7035 , pp. 917-921
- Farmer, H.¹ McCabe, H.² Lord, C.J.³ Tutt, A.H.J.⁴ Johnson, D.A.⁵ Richardson, T.B.⁶ Santarosa, M.⁷ Dillon, K.J.⁸ Hickson, I.⁹ Knights, C.¹⁰ Martin, N.M.B.¹¹ Jackson, S.P.¹² Smith, G.C.M.¹³ Ashworth, A.¹⁴

3
- 67650471685
- Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers
- P.C. Fong, D.S. Boss, T.A. Yap, A. Tutt, P. Wu, M. Mergui-Roelvink, P. Mortimer, H. Swaisland, A. Lau, and M.J. O'Connor Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers N. Engl. J. Med. 361 2009 123 134
- (2009) N. Engl. J. Med. , vol.361 , pp. 123-134
- Fong, P.C.¹ Boss, D.S.² Yap, T.A.³ Tutt, A.⁴ Wu, P.⁵ Mergui-Roelvink, M.⁶ Mortimer, P.⁷ Swaisland, H.⁸ Lau, A.⁹ O'Connor, M.J.¹⁰

4
- 77955019276
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial
- A. Tutt, M. Robson, J.E. Garber, S.M. Domchek, M.W. Audeh, J.N. Weitzel, M. Friedlander, B. Arun, N. Loman, and R.K. Schmutzler Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial Lancet 376 2010 235 244
- (2010) Lancet , vol.376 , pp. 235-244
- Tutt, A.¹ Robson, M.² Garber, J.E.³ Domchek, S.M.⁴ Audeh, M.W.⁵ Weitzel, J.N.⁶ Friedlander, M.⁷ Arun, B.⁸ Loman, N.⁹ Schmutzler, R.K.¹⁰

5
- 0142240342
- BRCT Repeats As Phosphopeptide-Binding Modules Involved in Protein Targeting
- DOI 10.1126/science.1088877
- I.A. Manke, D.M. Lowery, A. Nguyen, and M.B. Yaffe BRCT repeats as phosphopeptide-binding modules involved in protein targeting Science 302 2003 636 639 (Pubitemid 37310918)
- (2003) Science , vol.302 , Issue.5645 , pp. 636-639
- Manke, I.A.¹ Lowery, D.M.² Nguyen, A.³ Yaffe, M.B.⁴

6
- 0142147272
- The BRCT Domain Is a Phospho-Protein Binding Domain
- DOI 10.1126/science.1088753
- X. Yu, C.C. Chini, M. He, G. Mer, and J. Chen The BRCT domain is a phospho-protein binding domain Science 302 2003 639 642 (Pubitemid 37310919)
- (2003) Science , vol.302 , Issue.5645 , pp. 639-642
- Yu, X.¹ Chini, C.C.S.² He, M.³ Mer, G.⁴ Chen, J.⁵

7
- 58549098527
- E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks
- L.J. Reid, R. Shakya, A.P. Modi, M. Lokshin, J.T. Cheng, M. Jasin, R. Baer, and T. Ludwig E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks Proc. Natl. Acad. Sci. USA 105 2008 20876 20881
- (2008) Proc. Natl. Acad. Sci. USA , vol.105 , pp. 20876-20881
- Reid, L.J.¹ Shakya, R.² Modi, A.P.³ Lokshin, M.⁴ Cheng, J.T.⁵ Jasin, M.⁶ Baer, R.⁷ Ludwig, T.⁸

8
- 80055092789
- BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity
- R. Shakya, L.J. Reid, C.R. Reczek, F. Cole, D. Egli, C.S. Lin, D.G. deRooij, S. Hirsch, K. Ravi, and J.B. Hicks BRCA1 tumor suppression depends on BRCT phosphoprotein binding, but not its E3 ligase activity Science 334 2011 525 528
- (2011) Science , vol.334 , pp. 525-528
- Shakya, R.¹ Reid, L.J.² Reczek, C.R.³ Cole, F.⁴ Egli, D.⁵ Lin, C.S.⁶ Derooij, D.G.⁷ Hirsch, S.⁸ Ravi, K.⁹ Hicks, J.B.¹⁰

9
- 83455229693
- BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance
- R. Drost, P. Bouwman, S. Rottenberg, U. Boon, E. Schut, S. Klarenbeek, C. Klijn, I. van der Heijden, H. van der Gulden, and E. Wientjens BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance Cancer Cell 20 2011 797 809
- (2011) Cancer Cell , vol.20 , pp. 797-809
- Drost, R.¹ Bouwman, P.² Rottenberg, S.³ Boon, U.⁴ Schut, E.⁵ Klarenbeek, S.⁶ Klijn, C.⁷ Van Der Heijden, I.⁸ Van Der Gulden, H.⁹ Wientjens, E.¹⁰

10
- 0037610801
- Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex
- DOI 10.1073/pnas.0836054100
- P.S. Brzovic, J.R. Keeffe, H. Nishikawa, K. Miyamoto, D. Fox 3rd, M. Fukuda, T. Ohta, and R. Klevit Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex Proc. Natl. Acad. Sci. USA 100 2003 5646 5651 (Pubitemid 36576862)
- (2003) Proceedings of the National Academy of Sciences of the United States of America , vol.100 , Issue.10 , pp. 5646-5651
- Brzovic, P.S.¹ Keeffe, J.R.² Nishikawa, H.³ Miyamoto, K.⁴ Fox III, D.⁵ Fukuda, M.⁶ Ohta, T.⁷ Klevit, R.⁸

11
- 32144463131
- Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility
- DOI 10.1093/hmg/ddi476
- J.R. Morris, L. Pangon, C. Boutell, T. Katagiri, N.H. Keep, and E. Solomon Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility Hum. Mol. Genet. 15 2006 599 606 (Pubitemid 43205424)
- (2006) Human Molecular Genetics , vol.15 , Issue.4 , pp. 599-606
- Morris, J.R.¹ Pangon, L.² Boutell, C.³ Katagiri, T.⁴ Keep, N.H.⁵ Solomon, E.⁶

12
- 84866651678
- The BRCA1 E3 ligase triggers Claspin ubiquitylation, CHK1 activation and homology-diretced repair during a subset of DNA-damage responses
- K. Sato, E. Sundaramoorthy, E. Rajendra, H. Hattori, A.D. Jeyasekharan, N. Ayoub, R. Schiess, R. Aebersold, H. Nishikawa, and A. Sedukhina The BRCA1 E3 ligase triggers Claspin ubiquitylation, CHK1 activation and homology-diretced repair during a subset of DNA-damage responses Curr. Biol. 22 2012 1659 1666
- (2012) Curr. Biol. , vol.22 , pp. 1659-1666
- Sato, K.¹ Sundaramoorthy, E.² Rajendra, E.³ Hattori, H.⁴ Jeyasekharan, A.D.⁵ Ayoub, N.⁶ Schiess, R.⁷ Aebersold, R.⁸ Nishikawa, H.⁹ Sedukhina, A.¹⁰

13
- 2342628449
- Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation
- DOI 10.1073/pnas.0401847101
- S.Y. Lin, K. Li, G.S. Stewart, and S.J. Elledge Human Claspin works with BRCA1 to both positively and negatively regulate cell proliferation Proc. Natl. Acad. Sci. USA 101 2004 6484 6489 (Pubitemid 38586000)
- (2004) Proceedings of the National Academy of Sciences of the United States of America , vol.101 , Issue.17 , pp. 6484-6489
- Lin, S.-Y.¹ Li, K.² Stewart, G.S.³ Elledge, S.J.⁴

14
- 39749178467
- Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia
- DOI 10.1093/hmg/ddm340
- J.H. Guervilly, G. Mace-Aime, and F. Rosselli Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia Hum. Mol. Genet. 17 2008 679 689 (Pubitemid 351292257)
- (2008) Human Molecular Genetics , vol.17 , Issue.5 , pp. 679-689
- Guervilly, J.-H.¹ Mace-Aime, G.² Rosselli, F.³

15
- 0035105291
- Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
- DOI 10.1016/S1097-2765(01)00173-3
- I. Garcia-Higuera, T. Taniguchi, S. Ganesan, M.S. Meyn, C. Timmers, J. Hejna, M. Grompe, and A.D. D'Andrea Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway Mol. Cell 7 2001 249 262 (Pubitemid 32206493)
- (2001) Molecular Cell , vol.7 , Issue.2 , pp. 249-262
- Garcia-Higuera, I.¹ Taniguchi, T.² Ganesan, S.³ Meyn M.Stephen⁴ Timmers, C.⁵ Hejna, J.⁶ Grompe, M.⁷ D'Andrea, A.D.⁸

16
- 33749034730
- Topoisomerase I inhibitors: Camptothecins and beyond
- DOI 10.1038/nrc1977, PII NRC1977
- Y. Pommier Topoisomerase I inhibitors: camptothecins and beyond Nat. Rev. Cancer 6 2006 789 802 (Pubitemid 44450467)
- (2006) Nature Reviews Cancer , vol.6 , Issue.10 , pp. 789-802
- Pommier, Y.¹

17
- 84862776819
- BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair
- S.F. Bunting, E. Callen, M.L. Kozak, J.M. Kim, N. Wong, A.J. Lopez-Contreras, T. Ludwig, R. Baer, R.B. Faryabi, and A. Malhowski BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair Mol. Cell 46 2012 125 135
- (2012) Mol. Cell , vol.46 , pp. 125-135
- Bunting, S.F.¹ Callen, E.² Kozak, M.L.³ Kim, J.M.⁴ Wong, N.⁵ Lopez-Contreras, A.J.⁶ Ludwig, T.⁷ Baer, R.⁸ Faryabi, R.B.⁹ Malhowski, A.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.